Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06230341
Other study ID # RC23_0402
Secondary ID RSP22N005
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date August 1, 2026

Study information

Verified date January 2024
Source Nantes University Hospital
Contact Jean-Baptiste Amélineau, MD
Phone 02 40 41 28 28
Email jean-baptiste.amelineau@univ-nantes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In France, improving the practice of health professionals working in coordinated primary care teams (health centres called Maisons de Santé Pluriprofessionnelles - MSPs) could be facilitated by a learning system consisting of (i) a risk management support programme and (ii) the provision of a comprehensive online system combining training, reporting and support for the analysis and management of patient safety incidents (PSIs). EVIDENS-Prim is a multi-method, multi-centre, prospective study. It aims to describe the PSIs that occur in MSPs, using an international classification system, and to describe the ways in which professionals have adopted a global approach to PSIs management, from PSI reporting to feedback.


Description:

This method combines: - (i) A sequential study of PSIs analysis. The sequential study will take place in three stages (coder training, collection of PSIs data via the web platform, PSIs coding). Each PSIs reported by professionals during the implementation of the risk management support programme will be coded using the PISA multi-axial classification system (based on the WHO's International Classification for Patient Safety in Primary Care). These codes will be used to describe PSIs in coordinated practice. - (ii) An implementation study of the learning system. The learning system is described in the intervention section. During the implementation study, two types of data collection (quantitative and qualitative) will be mobilised at the end of the support to the QualiREL Santé Regional Support Structure. The main objective of the study is: - To Describe PSIs occurring in MSPs as part of the coordinated exercise and over an 18-month period, according to the 4 coding frameworks of the PISA classification: (i) types of events (main and contributing), (ii) contributing factors, (iii) outcomes of PSIs, (iv) severity of harm. The secondary objectives, linked to the evaluation of the implementation of the learning system, are - To examine the acceptance of the learning system by the teams, - To describe the effective use of the web platform by professionals, - To describe the MSP's ownership of the risk management support programme.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 15
Est. completion date August 1, 2026
Est. primary completion date July 1, 2026
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Characteristics of the MSPs included in the study: - Located in the Pays de la Loire region; - Having a contract with a health insurance (specifications and financing defined nationally) for at least 1 year; - Agreeing to take part in the project; - Having a quality representative or committing to appoint one when they join the project. Characteristics of professionals working in MSPs included: - All independent health professionals involved in the MSP: general practitioners and, depending on the MSP, nurses, pharmacists, podiatrists, physiotherapists, midwives, speech therapists, dentists, occupational therapists, psychomotor therapists, etc,) - All professionals involved in MSP outside the health sector: (coordinators, medical assistants, independent psychologists, etc.), - agree to take part in the project. Exclusion Criteria: Other group exercise modalities or other forms of coordinated exercise (other than MSP) do not have a quality representative on their team and will not be considered for inclusion. Characteristics of MSPs not included in the research: - Where the members of the research team work. Characteristics of professionals working in MSPs included: - Not included.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Health Services Research
MSPs benefit from a learning system. The learning system combines an individualised support programme provided by a regional support structure for quality and safety in health care (QualiREL Santé) and the provision of a web platform. Based on the 4 dimensions of the Shortell model, the support programme includes initial training (6 months) and personalised methodological support (18 months) for each MSP. A web platform is provided to MSPs to enable them to implement the full approach of the Risk Management Support Programme. It provides support for reporting, analysis and management of PSIs.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Nantes University Hospital Université de Nantes

Outcome

Type Measure Description Time frame Safety issue
Primary Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 1-by type Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by type: the number of PSIs for each type out of the total number of PSIs reported. PSIs reported by MSP professionals in the 18 months following the initial training provided
Primary Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 2- by contributing factors Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by contributing factors : number of PSIs for each contributing factor (e.g. factors related to the patient, staff, equipment, organisation, etc.) out of the total number of PSIs reported. 18 months
Primary Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 3-by results Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by results: number of PSIs for each result (no harm, clinical harm, team harm) out of the total number of PSIs reported. 18 months
Primary Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 4-by severity Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by severity: number of PSIs of each severity (e.g. no harm, mild, moderate or severe harm, death) out of the total number of PSIs reported. 18 months
Secondary Description of MSP professionals' acceptance of learning system Analysis of the main themes and sub-themes of the acceptability of the learning system from the semi-directed interviews and focus groups conducted with MSP professionals. 3 months
Secondary Description of the behaviour of users of the online system in the 18 months following the provision of initial training Export from the web platform of
the number of professionals who have validated the opening of their account on the web platform,
the number of professionals who have declared at least one PSI,
the number of modifications made to the PSIs declaration,
the number of declarations in anonymous mode,
the number of updates of action sheets corresponding to improvement actions.
18 months
Secondary Description of the MSP's behaviour in implementing the risk management support programme during the 18 months following the provision of the initial training. Description: Export from the web platform of
the number of PSI declarations
the number of systemic analyses of PSIs carried out,
the number of types of contributing factors identified by the analysis (variable categories defined according to the analysis methods),
the number of analyses identifying security barriers (by type: present and effective / present and ineffective / absent),
the number of improvement actions planned / completed / abandoned.
18 months
See also
  Status Clinical Trial Phase
Recruiting NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Phase 2/Phase 3
Completed NCT05232656 - PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Completed NCT05133817 - Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension N/A
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Recruiting NCT05462938 - Conscious Sedation for Transcatheter Aortic Valve Implantation N/A
Completed NCT04562922 - LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Phase 2
Recruiting NCT03740464 - Long-acting G-CSF for Febrile Neutropenia Phase 3
Completed NCT03332433 - High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol N/A
Not yet recruiting NCT04615156 - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography Phase 3
Recruiting NCT03381534 - Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting N/A
Completed NCT04570488 - Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
Recruiting NCT05369962 - Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
Completed NCT05321160 - Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT03745677 - Redesigning Systems to Improve Quality for Hospitalized Patients N/A
Completed NCT04763876 - Intramuscular Ketorolac at Two Single-Dose Regimens Phase 4
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A